SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-455395
Filing Date
2016-02-09
Accepted
2016-02-09 16:38:24
Documents
58
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d106818d10q.htm 10-Q 541251
2 EX-10.1 d106818dex101.htm EX-10.1 806540
3 EX-31.1 d106818dex311.htm EX-31.1 8219
4 EX-31.2 d106818dex312.htm EX-31.2 8205
5 EX-32.1 d106818dex321.htm EX-32.1 4280
12 GRAPHIC g106818g80n99.jpg GRAPHIC 154510
  Complete submission text file 0001193125-16-455395.txt   3979937

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enta-20151231.xml EX-101.INS 443736
7 XBRL TAXONOMY EXTENSION SCHEMA enta-20151231.xsd EX-101.SCH 33286
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20151231_cal.xml EX-101.CAL 61894
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20151231_def.xml EX-101.DEF 137862
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20151231_lab.xml EX-101.LAB 310472
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20151231_pre.xml EX-101.PRE 231474
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 161400484
SIC: 2834 Pharmaceutical Preparations